Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin

Biotechnology Letters

Volumn 33, Issue 4, 2011, Pages 845-851

  Bhang, Suk Ho ^a   Sun, Ah Young ^b   Yang, Hee Seok ^b   Rhim, Taiyoun ^b   Kim, Dong Ik ^c   Kim, Byung Soo ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Fibroblast growth factor 2; Heparin conjugated fibrin; Skin regeneration; Vascularization

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARIN-CONJUGATED FIBRIN; NEOVASCULARIZATION; SKIN DEFECTS; SKIN REGENERATION; VASCULARIZATION; WOUND HEALING;

CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; PEPTIDES; POLYSACCHARIDES;

BIOMATERIALS;

FIBRIN; FIBROBLAST GROWTH FACTOR 2; HEPARIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; REGENERATION; SKIN; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; FIBRIN; FIBROBLAST GROWTH FACTOR 2; HEPARIN; IMMUNOHISTOCHEMISTRY; MICE; REGENERATION; SKIN; WOUND HEALING;

MUS;

EID: 79952743354     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-010-0492-5     Document Type: Article

References (23)

1. Akimoto N, Sato T, Sakiguchi T et al (2002) Cell proliferation and lipid formation in hamster sebaceous gland cells. Dermatology 204: 118-123.
2. Andreadis ST, Hamoen KE, Yarmush ML et al (2001) Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J 15: 898-906.
3. Badiavas EV, Abedi M, Butmarc J et al (2003) Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196: 245-250.
4. Davidson JM, Klagsburn M, Hill KE et al (1985) Accelerated wound repair, cell proliferation and collagen accumulation are produced by cartilage-derived growth factor. J Cell Biol 100: 1219-1227.
5. Davidson JM, Buckley A, Woodward S et al (1988) Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factor. Prog Clin Biol Res 266: 63-75.
6. Elcin YM, Dixit V, Gitnick G (2001) Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs 25: 558-565.
7. Epstein SE, Fuchs S, Zhou YF et al (2001) Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49: 532-542.
8. Finetti G, Farina M (1992) Recombinant human basic-fibroblastic growth factor: different medical dressings for clinical application in wound healing. Farmaco 47: 967-978.
9. Folkman J, Shing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313: 355-364.
10. Hebda PA, Klingbeil CK, Abraham JA et al (1990) Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 95: 626-631.
11. Li J, Zhang YP, Kirsner RS (2003) Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Technol 60: 107-114.
12. McGee GS, Davidson JM, Buckley A et al (1988) Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 45: 145-153.
13. Nimni ME (1997) Polypeptide growth factors: targeted delivery systems. Biomaterials 18: 1201-1225.
14. Putney SD, Burke PA (1998) Improving protein therapeutics with sustained release formulations. Nat Biotechnol 16: 153-157.
15. Rehman J, Li J, Orschell CM et al (2003) Peripheral blood endothelial progenitor cells are derived from monocytes/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
16. Richard JL, Parer-Richard C, Daures JP et al (1995) Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 18: 64-69.
17. Scott G, Stoler M, Sarkar S et al (1991) Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J Invest Dermatol 96: 318-322.
18. Suh W, Kim KL, Kim JM et al (2005) Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23: 1571-1578.
19. Werner S, Weinbert W, Liao X et al (1993) Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J 12: 2635-2643.
20. Wu Y, Chen L, Scott PG et al (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659.
21. Yang HS, La WG, Bhang SH et al (2009) Heparin-conjugated fibrin as an injectable system for sustained delivery of BMP-2. Tissue Eng Part A 16: 1225-1233.
22. Yang HS, Bhang SH, Hwang JW et al (2010) Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. Tissue Eng Part A 16: 2113-2119.
23. Zhou F, Hook T, Thompson JA et al (1992) Heparin and protein interactions. In: Lane DA (ed) Heparin and related polysaccharides. Plenum Press, New York, pp 141-153.